After a dismal pre-opening projection, and then a much sunnier mid-weekend forecast, MELANIA’s opening weekend box office topped the former, but fell short of the latter. As of Saturday afternoon, ...
Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...
The use of GLP-1 receptor agonists has expanded far beyond diabetes, transforming care for patients with obesity, cardiovascular disease, and other chronic conditions. Prescriptions are rising rapidly ...
Financial Distress Screening and Financial Navigation Among Adolescents and Young Adults Within the National Cancer Institute Community Oncology Research Program: Results of the 2022 Landscape Survey ...
Torie Bosch is the First Opinion editor at STAT. Welcome to the “First Opinion Podcast.” I’m Torie Bosch, editor of First Opinion. First Opinion is STAT’s home for big, bold ideas from health care ...
For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...
Current idiopathic pulmonary fibrosis (IPF) trials often exclude diverse patient perspectives, leading to unrepresentative conclusions and limited patient engagement. Issues identified include ...
Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...
Perspective Therapeutics, Inc. announced the dosing of the first patient in a new cohort of its Phase 1/2a trial assessing the safety of [212Pb]VMT01, a targeted alpha-particle therapy for melanoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results